Yahoo Web Search

Search results

1. • 

     Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock

     Benzinga via Yahoo Finance· 1 year ago

     Cantor Fitzgerald initiated coverage on Editas Medicine Inc (NASDAQ: EDIT) with an Overweight rating...

2. • Q2 2023 Thermogenesis Holdings Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 9 months ago

     Participants Paula Schwartz; IR; Rx Communications Group, LLC Chris Xu; CEO; ThermoGenesis Holdings, Inc. Jeff Cauble; CFO; ThermoGenesis Holdings, Inc. Sean Lee; Analyst; H.C. Wainwright & ...

3. • 

     Celyad Oncology SA (NASDAQ:CYAD) Q4 2022 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 1 year ago

     Celyad Oncology SA (NASDAQ:CYAD) Q4 2022 Earnings Call Transcript March 24, 2023 Operator:...

4. • 

     Editas Medicine, Inc. (NASDAQ:EDIT) Q3 2023 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 6 months ago

     Editas Medicine, Inc. (NASDAQ:EDIT) Q3 2023 Earnings Call Transcript November 3, 2023 Editas...

5. • Q1 2024 Editas Medicine Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 2 days ago

     Participants Christy Barnhart; IR; Editas Medicine, Inc. Gilmore O’Neill; CEO, President; Editas Medicine, Inc. Baisong Mei; EVP, Chief Medical Officer; Editas Medicine, Inc. Linda Burkly; EVP ...

6. • 

     Amicus' (FOLD) Galafold Aids Growth, Overdependence a Woe

     Zacks via Yahoo Finance· 2 years ago

     Currently, Amicus Therapeutics (FOLD) has only one marketed product in its portfolio, the Fabry...

7. • 

     Dr. Robert Lufkin and Dr. Stephen Sideroff Join Forces on Their "Path of Longevity Summit" April...

     NewMediaWire via Yahoo Finance· 1 year ago

     Reverse Inflammaging Summit: Beverly Hills, CA - (NewMediaWire) - February 28, 2023 - ANNOUNCED...